Text Size

A Comparison of Diabetes Group Education as Administered Through Telemedicine Versus as Administered in Person

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2008 by State University of New York - Upstate Medical University.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
State University of New York - Upstate Medical University
ClinicalTrials.gov Identifier:
NCT00629434
First received: February 25, 2008
Last updated: March 4, 2008
Last verified: February 2008
History of Changes
  Purpose

This study compares group diabetes education in-person versus via telemedicine


Condition Intervention
Diabetes Mellitus
 Other: diabetes education via telemedicine
Other: diabetes education in-person

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: A Comparison of Diabetes Group Education as Administered Through Telemedicine Versus as Administered in Person

Resource links provided by NLM:

MedlinePlus related topics: Diabetes
U.S. FDA Resources

Further study details as provided by State University of New York - Upstate Medical University:

Primary Outcome Measures:
  • A1c [ Time Frame: baseline, 3 mo post intervention, 6 mo post intervention ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • PAID scale [ Time Frame: baseline, 3 and 6 months post intervention ] [ Designated as safety issue: No ]
  • Diabetes Treatment Satisfaction Questionnaire [ Time Frame: Baseline, 3 and 6 months post intervention ] [ Designated as safety issue: No ]

Enrollment: 68
Study Start Date: June 2001
Estimated Study Completion Date: August 2008
Estimated Primary Completion Date: June 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
This arm will receive diabetes education via telemedicine
 Other: diabetes education via telemedicine
This arm will receive diabetes group education via telemedicine
Active Comparator: 2
diabetes education in-person
 Other: diabetes education in-person
In this arm the group of patients with diabetes will receive diabetes education in-person

Detailed Description:

Diabetes education is important in the treatment of the person with diabetes. A diabetes self-management education program not only educates the patient and his/her family to the basics of diabetes care but also integrates diabetes care into daily life while providing coping skills to adjust to this chronic illness. Unfortunately, comprehensive diabetes care is not available to all persons with diabetes. One obstacle to the provision of comprehensive diabetes care is the unavailability of a diabetes treatment center. many people with diabetes live too far or do not have the transportation to be able to attend education programs that met national standards. We have shown that telemedicine is an effective means to provide comprehensive 1:1 individualized diabetes education to persons with diabetes. We now propose to test the hypothesis that diabetes groups education classes can be provided effectively through telemedicine technology to individuals living in rural areas. Patients with diabetes will received diabetes education via teleconferencing from our Joslin Diabetes center. The participants will be assessed before and after diabetes education via telemedicine using measures of glycemia (A1c) and assessments of patient satisfaction, emotional well being, and behavioral change and compared to results from participants attending our diabetes education classes in-person.

  Eligibility

Ages Eligible for Study:   18 Years to 85 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Type 1 or type 2 diabetes mellitus
  • age > 18 years

Exclusion Criteria:

  • Profound vision loss
  • Severe hearing impairment
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00629434

Locations
United States, New York
Joslin Diabetes Center Affiliate at SUNY Upstate Medical University
Syracuse, New York, United States, 13214
Sponsors and Collaborators
State University of New York - Upstate Medical University
  More Information

No publications provided

Responsible Party: Roberto Izquierdo, MD, SUNY Upstate Medical University
ClinicalTrials.gov Identifier: NCT00629434     History of Changes
Other Study ID Numbers: UMU IRB # 4510F, UMU IRB # 4510F
Study First Received: February 25, 2008
Last Updated: March 4, 2008
Health Authority: United States: Institutional Review Board

Keywords provided by State University of New York - Upstate Medical University:
Diabetes Education
Telemedicine

Additional relevant MeSH terms:
Diabetes Mellitus
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases

ClinicalTrials.gov processed this record on May 19, 2013